Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;69(7):e29760.
doi: 10.1002/pbc.29760. Epub 2022 May 13.

SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia

Kirsty Hillier  1 , Jennifer A Rothman  2 , Robert J Klaassen  3 , Cindy Neunert  4 , Melissa J Rose  5 , Rachael F Grace  6 , Michele P Lambert  7   8
Affiliations

SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia

Kirsty Hillier et al. Pediatr Blood Cancer. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Jennifer A. Rothman: research funding: Novartis, Agios Pharmaceuticals, Bluebird Bio, Dova Pharmaceuticals, Sobi; consultancy: Agios. Robert J. Klaassen: consultancy: Agios Pharmaceuticals Inc, Amgen Inc, Hoffman‐LaRoche Ltd, Novo Nordisk Canada Inc, Biogen Canada Limited, Octapharma AG, Takeda Canada Inc, and Sanofi Genzyme Inc. Cindy Neunert: consultancy: Dova. Rachael F. Grace: research funding: Agios, Dova, Novartis; consultancy: Agios, Principia. Michele P. Lambert: research funding: Sysmex, Novartis, Rigel, Principia, Argenx, Dova, Octapharma, Janssen, Sanofi, and Astra Zeneca; consultancy: Novartis, Shionogi, Dova, Principia, Argenx, Rigel, and Sanofi; advisory board member: Octapharma, Dova, Principia, and Shionogi.

References

    1. FDA . FDA Authorizes Pfizer‐BioNTech COVID‐19 Vaccine for Emergency Use in Children 5 through 11 Years of Age . FDA; 2021. https://www.fda.gov/news‐events/press‐announcements/fda‐authorizes‐pfize.... Accessed February 7, 2022.
    1. Grady D, Mazzei P. Doctor's death after COVID vaccine is being investigated. The New York Times. January 12, 2021. https://www.ncbi.nlm.nih.gov/search/research‐news/12431/. Accessed February 7, 2022.
    1. Collins EC, Carr MJ, Kim JS, et al. Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination. J Am Coll Emerg Physicians Open. 2021;2(5):e12531. - PMC - PubMed
    1. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID‐19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2021;39(25):3329‐3332. - PMC - PubMed
    1. Lee EJ, Beltrami‐Moreira M, Al‐Samkari H, et al. SARS‐CoV‐2 vaccination and immune thrombocytopenia in de novo and pre‐existing ITP patients. Blood. 2022;139(10):1564‐1574. - PMC - PubMed

Substances